# Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)

> **NCT04826562** · PHASE4 · UNKNOWN · sponsor: **Saint Michael's Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **DRUG:** Dolutegravir/Lamivudine

## Key facts

- **NCT ID:** NCT04826562
- **Lead sponsor:** Saint Michael's Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-26
- **Primary completion:** 2023-10-06
- **Final completion:** 2023-12-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04826562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04826562, "Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04826562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*